Department of Pharmacology & Chemical Biology at the University of Pittsburgh
Jennifer Xavier, PhD
Research Assistant Professor
Magee Womens Research Institute 204 Craft Avenue, Room B401
Pittsburgh, PA 15213

Email:
xavierjm@mwri.magee.edu
Phone: 412-641-7521

Fax: 412-641-2458


Education
BSc (Pharmacology), Newcastle University, United Kingdom (2003)
PhD (Pharmacology), University of Bradford, United Kingdom (2007)
Postdoctoral Fellow, St. Jude Children's Research Hospital, Memphis, TN (2011)
Postdoctoral Fellow, Eli Lilly and Company, Indianapolis, IN (2013)
Photo of Jennifer Xavier, PhD





Important Publications
Atkinson JM, Rank K, Capen D, Engler T and Chedid M. Activating the Wnt/b-catenin pathway for the treatment of human melanoma – application of LY2090314, a novel small molecule selective inhibitor of GSK3. PLoS One 10:e0125028, 2015.
Atkinson JM and Gilbertson RJ. Developing treatment strategies for rare cancers. Oncotarget 2:657, 2011.
Atkinson JM, Shelat AA, Carcabosis AM, Kranenburg TA, Arnold LA, Boulos N, Wright KD, Johnson RA, Poppleton H, Mohankumar MM, Feau C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung A, Gajjar A, Stewart CF, Guy RK and Gilbertson RJ. An integrated in vitro and in vivo high throughput screen identifies treatment leads for ependymoma. Cancer Cell 20: 384-399, 2011.
Atkinson JM, Falconer RA, Patterson LH, Gill JH and Loadman PM. Development of novel matrix metalloproteinase (MMP) targeted peptide conjugated antivascular agents. Cancer Research 70:6902-6912, 2010.
Johnson R, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Rand V, Leary S, White E, Eden C, Hogg T, Pounds S, Northcott P, Mack S, Neale G, Coyle B, Atkinson JM, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG and Gilbertson RJ. Cross-species genomics matches driver mutations and cell compartments to model Ependymoma. Nature 466:632-636, 2010.




Back to Top